Surgery Planning Innovation In Medicine
One of the most important things I learned this year came from a deep dive into GLP-1 medications and how they impact the body before and after plastic surgery.
These medications don't just affect weight — they influence healing, nutrition, muscle mass, and surgical planning.
Understanding when and how to use them has completely changed the way I approach patient care.
This isn't about trends.
It's about doing the right research and applying it responsibly to get better, safer results. #PlasticSurgeryEducation #PatientCare
In my personal practice, integrating knowledge about GLP-1 medications has revolutionized my approach to surgery planning. These drugs, originally used for managing diabetes and weight, do much more—they influence key aspects of patient recovery such as tissue healing, nutritional status, and muscle retention. For example, I have observed that patients on GLP-1 therapies require careful timing adjustments regarding surgery dates to optimize their healing potential. Before I started considering GLP-1 impacts, some patients experienced delayed wound healing or unexpected nutritional challenges that complicated recovery. Now, I engage in detailed preoperative evaluations to assess how these medications might affect each individual's surgical journey. This includes collaborating with endocrinologists and nutritionists to ensure we support muscle maintenance and adequate nutrition. This shift has not only improved safety but has also enhanced patient satisfaction by reducing complications and accelerating recovery timelines. It taught me that staying informed on emerging pharmaceutical effects outside their original indications is vital for evolving patient care. Ultimately, this practice embodies responsible research application rather than following fleeting trends, enabling better tailored treatment plans that prioritize patient wellness and surgical success.
I like that you make sure you’re patient is good and not just good kool🔥🔥🔥🔥🔥🔥🔥